The lymphoid chemokine CCL21 costimulates naïve T cell expansion and Th1 polarization of non-regulatory CD4+ T cells

Cellular Immunology

Volumn 231, Issue 1-2, 2004, Pages 75-84

  Flanagan, Kenneth ^a   Moroziewicz, Dorota ^a   Kwak, Heesun ^a   Hörig, Heidi ^a   Kaufman, Howard L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Chemokines; Chemotaxis; Costimulation; Regulatory T cells; T cell differentiation; T lymphocytes

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HELPER CELL; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD4; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES, CC; CYTOKINES; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-2; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES; TH1 CELLS;

EID: 20144361987     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.12.006     Document Type: Article

References (33)

1. C.J. Kirk, D. Hartigan-O'Connor, B.J. Nickoloff, J.S. Chamberlain, M. Giedlin, L. Aukerman, and J.J. Mule T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy Cancer Res. 61 2001 2062 2070
2. K. Flanagan, R.T. Glover, H. Hörig, W. Yang, and H.L. Kaufman Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T cell dependent antitumor response Vaccine 22 2004 2894 2903
3. C.J. Kirk, D. Hartigan-O'Connor, and J.J. Mule The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally Cancer Res. 61 2001 8794 8802
4. E.A. Greenfield, K.A. Nguyen, and V.K. Kuchroo CD28/B7 costimulation: a review Crit. Rev. Immunol. 18 1998 389 418
5. L.J. Appleman, D. Tzachanis, T. Grader-Beck, A.A. van Puijenbroek, and V.A. Boussiotis Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics J. Mol. Med. 78 2001 673 683
6. S.A. Luther, and J.G. Cyster Chemokines as regulators of T cell differentiation Nat. Immunol. 2 2001 102 107
7. D.D. Taub, S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro J. Immunol. 156 1996 2095 2103
8. B. Moser, and P. Loetscher Lymphocyte traffic control by chemokines Nat. Immunol. 2 2001 123 128
9. J.N. Blattman, R. Antia, D.J. Sourdive, X. Wang, S.M. Kaech, K. Murali-Krishna, J.D. Altman, and R. Ahmed Estimating the precursor frequency of naive antigen-specific CD8 T cells J. Exp. Med. 195 2002 657 664
10. S. Sozzani, P. Allavena, A. Vecchi, and A. Mantovani Chemokines and dendritic cell traffic J. Clin. Immunol. 20 2000 151 160
11. G. Constantin, M. Majeed, C. Giagulli, L. Piccio, J.Y. Kim, E.C. Butcher, and C. Laudanna Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow Immunity 13 2000 759 769
12. J.V. Stein, S.F. Soriano, C. M'Rini, C. Nombela-Arrieta, G.G. de Buitrago, J.M. Rodriguez-Frade, M. Mellado, J.P. Girard, and A.C. Martinez CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway Blood 101 2003 38 44
13. A. Poggi, R. Carosio, D. Fenoglio, S. Brenci, G. Murdaca, M. Setti, F. Indiveri, S. Scabini, E. Ferrero, and M.R. Zocchi Migration of V{delta}1 and V{delta}2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1 infected patients: competition by HIV-1 TAT Blood 103 2003 2205 2213
14. E. Scandella, Y. Men, D.F. Legler, S. Gillessen, L. Prikler, B. Ludewig, and M. Groettrup CCL19/CCL21-triggered signal transduction and migration of dendritic cells require prostaglandin E2 Blood 103 2004 1595 1601
15. + regulatory T cells J. Exp. Med. 199 2004 303 313
16. K. Inaba, M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J. Exp. Med. 176 1992 1693 1702
17. C.H. Kim, L.M. Pelus, J.R. White, E. Applebaum, K. Johanson, and H.E. Broxmeyer CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells J. Immunol. 160 1998 2418 2424
18. S.A. Kellermann, S. Hudak, E.R. Oldham, Y.J. Liu, and L.M. McEvoy The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells J. Immunol. 162 1999 3859 3864
19. M.D. Gunn, K. Tangemann, C. Tam, J.G. Cyster, S.D. Rosen, and L.T. Williams A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes Proc. Natl. Acad. Sci. USA 95 1998 258 263
20. S.A. Luther, A. Bidgol, D.C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J.G. Cyster Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis J. Immunol. 169 2002 424 433
21. M. Moser, and K.M. Murphy Dendritic cell regulation of TH1-TH2 development Nat. Immunol. 1 2000 199 205
22. S. Oki, N. Otsuki, T. Kohsaka, and M. Azuma Stat6 activation and Th2 cell differentiation [correction of proliferation] driven by CD28 [correction of CD28 signals] Eur. J. Immunol. 30 2000 1416 1424
23. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T.W. Mak, and S. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J. Exp. Med. 192 2000 303 310
24. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J. Exp. Med. 188 1998 287 296
25. + regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease Curr. Mol. Med. 3 2003 693 706
26. M.L. Dustin The immunological synapse Arthritis Res. 4 Suppl. 3 2002 S119 S125
27. O.D. Perez, D. Mitchell, G.C. Jager, S. South, C. Murriel, J. McBride, L.A. Herzenberg, S. Kinoshita, and G.P. Nolan Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1 Nat. Immunol. 4 2003 1083 1092
28. T.A. Kohout, S.L. Nicholas, S.J. Perry, G. Reinhart, S. Junger, and R.S. Struthers Differential desensitization, receptor phosphorylation, beta arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7 J. Biol. Chem. 279 2004 23214 23222
29. F. Katou, H. Ohtani, T. Nakayama, H. Nagura, O. Yoshie, and K. Motegi Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin J. Pathol. 199 2003 98 106
30. K. Nakamura, A. Kitani, and W. Strober Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J. Exp. Med. 194 2001 629 644
31. + regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu. Rev. Immunol. 22 2004 531 562
32. A.P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms J. Immunol. 165 2000 1992 2000
33. S. Sharma, M. Stolina, J. Luo, R.M. Strieter, M. Burdick, L.X. Zhu, R.K. Batra, and S.M. Dubinett Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo J. Immunol. 164 2000 4558 4563